Towards a cancer mission in Horizon Europe: recommendations
Anton Berns(Oncode Institute), Emile E. Voest(University Medical Center Utrecht), Douglas Hanahan(Ludwig Cancer Research), Peter Strang(Karolinska Institutet), Jérôme Foucaud(Institut National du Cancer), Josep Tabernero(Deaconess Hospital), Kathi Apostolidis(European CanCer Organisation), Miklós Kásler(National Institute of Oncology), Éric Solary(Inserm), Ulrik Ringborg(Karolinska University Hospital), Yvonne Brandberg(Karolinska Institutet), Hans‐Olov Adami(Harvard University), René Bernards(The Netherlands Cancer Institute), Gerd Nettekoven(German Cancer Research Center), Joachim Schüz(Centre international de recherche sur le cancer), Caroline Dive(University of Manchester), Sakari Karjalainen(Tampere University), Bengt Jönsson(Stockholm School of Economics), Alexander M.M. Eggermont(University Medical Center Utrecht), Pamela Kearns(National Institute for Health and Care Research), Ulrike Helbig(German Cancer Research Center), Angelika Eggert(MSB Medical School Berlin), Alberto Bardelli(IFOM), Péter Nagy(Semmelweis University), Nancy Abou‐Zeid(Fondation ARC pour la Recherche sur le Cancer), Mette Kalager(University of Oslo), Francesco De Lorenzo(European CanCer Organisation), Simon Oberst(Cancer Research UK), Michaël Baumann(Kantonsspital St. Gallen), M. V. Heitor(Ministry of Education Science and Technology), Neil K. Aaronson(The Netherlands Cancer Institute), Carlos Caldas(University of Cambridge), Richard Price(European CanCer Organisation), Denis Lacombe(European Organisation for Research and Treatment of Cancer), Fabien Calvo, Thierry Philip(Centre Léon Bérard), Julio E. Celis(Karolinska University Hospital), F. Falkenburg(Dutch Cancer Society), Klas Kärre(Karolinska Institutet), Françoise Meunier(Fondation FondaMental), Carolina Espina(Centre international de recherche sur le cancer)
Cited by 46
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k